The finding that antibody sialylation can suppress inflammation provides new opportunities for drug development.
References
Tanner, J.F. Cancer Metastasis Rev. 24, 585–598 (2005).
Kaneko, Y., Nimmerjahn, F. & Ravetch, J.V. Science 313, 670–673 (2006).
Deisenhofer, J. Biochemistry 20, 2361–2370 (1981).
Jefferis, R. Biotechnol. Prog. 21, 11–16 (2005).
Nimmerjahn, F. & Ravetch, J.V. Immunity 24, 19–28 (2006).
Hamilton et al. Science 313, 1441–1443 (2006).
Niwa, R. et al. J. Immunol. Meth. 306, 151–160 (2006).
Ferrara, C. et al. Biotechnol. Bioeng. 93, 851–861 (2006).
Sondermann, P. et al. Nature 406, 267–273 (2003).
Krapp, S. et al. J. Mol. Biol. 325, 979–989 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jefferis, R. A sugar switch for anti-inflammatory antibodies. Nat Biotechnol 24, 1230–1231 (2006). https://doi.org/10.1038/nbt1006-1230
Issue Date:
DOI: https://doi.org/10.1038/nbt1006-1230
- Springer Nature America, Inc.